Brief: Inventiva, Sino Biopharm Report Licensing And Collaboration Agreement
Sept 21 (Reuters) - Inventiva SA IVAA.PA :
* INVENTIVA AND SINO BIOPHARM ANNOUNCE LICENSING AND
COLLABORATION
AGREEMENT TO DEVELOP AND COMMERCIALIZE LANIFIBRANOR IN GREATER
CHINA
* INVENTIVA SA - CO WILL RECEIVE A $12 MILLION UPFRONT, $5
MILLION
IN SHORT TERM POTENTIAL MILESTONE PAYMENTS
* INVENTIVA SA - WILL RECEIVE UP TO $290 MILLION OF
CLINICAL,
REGULATORY AND COMMERCIAL MILESTONE PAYMENTS, IN ADDITION TO
TIERED ROYALTIES
Source text for Eikon: ID:nGNXc3Cq5t
Further company coverage: IVAA.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inventiva SA
See all newsFrance's Inventiva H1 net loss narrows
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Inventiva Announces Last Patient Visit In Nativ3 Phase 3 Clinical Trial Of Lanifibranor In Mash
Brief: Inventiva Announces Comprehensive Capital Structure Optimization Including Debt And Equity Financing In Advance Of The Anticipated Phase 3 Readout
Brief: Inventiva Secures Up To €150 Mln Debt Financing, Extends Debt Maturity To 2030